Cystic fibrosis: potential management through manipulation of the secretory process in affected exocrine glands.
D000818:Animals; D002415:Cats; D003550:Cystic Fibrosis / Q000503:physiopathology / Q000628:therapy*; D005088:Exocrine Glands / Q000187:drug effects / Q000378:metabolism*; D005289:Ferrets; D007545:Isoproterenol / Q000494:pharmacology; D046911:Macromolecular Substances; D009093:Mucus / Q000378:metabolism; D010306:Parotid Gland / Q000187:drug effects; D051381:Rats; D012463:Saliva / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D014132:Trachea / Q000187:drug effects; D014882:Water-Electrolyte Balance
D046911:Macromolecular Substances; D012964:Sodium; D007545:Isoproterenol